Diagnosis and management of attention-deficit/hyperactivity disorder in children, young people, and adults: summary of NICE guidance
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is a common childhood condition that may affect different areas of the child’s life, seriously impairing academic achievement, peer relationships, and self care. Many affected children become socially isolated and develop conduct problems. Some 15% of children with ADHD will still have the condition in adulthood, and even more will develop a personality disorder and/or a substance misuse disorder in adulthood.1 2 3 Diagnosis rates for ADHD and prescriptions of stimulant medication have risen substantially in England during the past decade, with 220 000 prescriptions for stimulants (costing about £5m (€6.3m; $9.4m)) in 1998 and 418 300 (almost £13m) in 2004.4 The prescription of stimulants, which are potential drugs of misuse, to children remains controversial, with concerns about their safety and the potential for misuse and diversion (where the drug is passed on to others for non-prescription use).This article summarises the most recent recommendations from the National Institute for Health and Clinical Excellence (NICE) on the diagnosis and management of ADHD in children, young people and adults.5 NICE recommendations are based on systematic reviews of best available evidence. When minimal evidence is available, recommendations are based on the guideline development group’s opinion of what constitutes good practice. Evidence levels for the recommendations are given in italic in square brackets. ### Service organisation and training of professionals Specialist ADHD teams for children and young people and equivalent teams for adults should jointly develop training programmes on the diagnosis and management of ADHD for all mental health, paediatric, social care, educational, forensic, and primary care providers who have contact with people with ADHD. [ Based on opinion of the Guideline Development Group ] ### Diagnosis and assessment
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886 · cited 1×
“There has also been an increase in the diagnosis of ADHD in adulthood, including those children with the diagnosis who have transferred to adult services and those diagnosed in adulthood. However, few adult psychiatrists are familiar with services and experienced in the treatment and diagnosis of ADHD in adults.”
BackgroundA Children's Global Assessment Scale (CGAS)
Shaffer, D. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790100074010 · Cited by 3,716
BIEDERMAN, J., MONUTEAUX, M. C., MICK, E., SPENCER, T., WILENS, T. E., SILVA, J. M., SNYDER, L. E., & FARAONE, S. V. (2006) · Psychological Medicine · doi:10.1017/s0033291705006410 · Cited by 850
Moffitt, T. E. (1990) · Child Development · doi:10.1111/j.1467-8624.1990.tb02830.x · Cited by 822
National trends in the treatment of attention deficit hyperactivity disorder
Olfson, M., Gameroff, M. J., Marcus, S. C., & Jensen, P. S. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.6.1071 · Cited by 394
Cited by
Kooij, S. J., Bejerot, S., Blackwell, A., Caci, H., Casas-Brugué, M., Carpentier, P. J., Edvinsson, D., Fayyad, J., Foeken, K., Fitzgerald, M., et al. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-67 · Cited by 928
“Atomoxetine is usually considered the second line treatment, followed by other non-stimulants like bupropion, guanfacine, modafinil and tricyclic antidepressents, based on efficacy outcomes in controlled studies in different age groups [239,261-264].”
European guidelines on managing adverse effects of medication for ADHD
(for the European Guidelines Group), Graham, J., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., Döpfner, M., Hamilton, R., Hollis, C., et al. (2011) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-010-0140-6 · Cited by 374
Self-citationDaley, D., Van Der Oord, S., Ferrin, M., Cortese, S., Danckaerts, M., Doepfner, M., Van den Hoofdakker, B. J., Coghill, D., Thompson, M., Asherson, P., et al. (2018) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12825 · Cited by 203
Self-citationMatheson, L., Asherson, P., Wong, I. C. K., Hodgkins, P., Setyawan, J., Sasane, R., & Clifford, S. (2013) · BMC Health Services Research · doi:10.1186/1472-6963-13-184 · Cited by 126
“Overall, these findings highlight the wide gap between recent NICE guidelines [20,21] and current practice in England regarding the clinical care for adults with ADHD, also supported by a recent article which argued that adults with ADHD are “ignored and under-treated” by services [45].”
BackgroundResultInfluentialBandeira, I. D., Guimarães, R. S. Q., Jagersbacher, J. G., Barretto, T. L., de Jesus-Silva, J. R., Santos, S. N., Argollo, N., & Lucena, R. (2016) · Journal of Child Neurology · doi:10.1177/0883073816630083 · Cited by 103
Metadata
- Authors
- Kendall, T., Taylor, E., Perez, A., Taylor, C., & on behalf of the Guideline Development Group
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2008-09-24
- Volume
- 337
- Issue
- sep24 1
- Pages
- a1239-a1239
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2042460577
- Cited by
- 115
- References
- 5
- FWCI
- 3.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diagnosis and management of attention-deficit/hyperactivity disorder in children, young people, and adults: summary of NICE guidance. https://app.cochat.ai/papers/10.1136/bmj.a1239
- The paper
- Kendall, T., Taylor, E., Perez, A., Taylor, C., & on behalf of the Guideline Development Group. (2008). Diagnosis and management of attention-deficit/hyperactivity disorder in children, young people, and adults: summary of NICE guidance. BMJ. https://doi.org/10.1136/bmj.a1239
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.